Concepedia

Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade

Umair Mahmood, Mai Anh Huynh, Joseph H. Killoran, Jack M. Qian, Eric H. Bent, Ayal A. Aizer, Raymond H. Mak, Harvey J. Mamon, Tracy A. Balboni, Lauren Gunasti,

International Journal of Radiation Oncology*Biology*Physics · 2022 · 15 citations · 14 references

DOI

Concepts

References

14

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

, , +15

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.9K citations

, , +15

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez, Chad Tang, Jianjun Zhang et al. · Journal of Clinical Oncology · 2019 · 1.3K citations · Full text

, , +15

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

, , +17

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer

Puneeth Iyengar, Zabi Wardak, David E. Gerber et al. · JAMA Oncology · 2017 · 1K citations

, , +13